Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 4:11 AM
Ignite Modification Date:
2025-12-26 @ 3:10 AM
NCT ID:
NCT00891020
Group ID:
EG002
Title:
Tocilizumab 8 mg/kg + DMARD
Description:
Participants received Tocilizumab 8 mg/kg as a 60 minute intravenous infusion every 4 weeks for a total of 6 infusion plus non-biologic disease-modifying antirheumatic drug (DMARD) of the investigator's choice for 24 weeks. The dosage could be decreased to 4 mg/kg for safety reasons at the investigator's discretion. Participants who completed the 24 week treatment period were offered the option of entering a long-term extension phase.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
40
Serious Number At Risk:
381
Other Number Affected:
189
Other Number At Risk:
381
Study:
NCT00891020
Results Section:
NCT00891020
Adverse Events Module:
NCT00891020